Inmune Bio’s $40.0 Million Shares Offering

Sichenzia Ross Ference represented Inmune Bio in the transaction.Inmune Bio, Inc. executed its registered direct offering of common stock at a purchase price of $22.00 per share with…

This content is for Standard 1 Year members only.
Login Join Now

Vehicle Accessories’ Acquisition of Maxton Group

Lumana’s $24 Million Series Seed Financing

Strattam Capital’s $308 Million Closing of its Third Flagship Fund

Grupo De Inversiones Suramericana (Grupo SURA)’s $500 Million Loan

G Mining Ventures Corp.’s Combination With Reunion Gold Corporation

AES Brasil Operacoes’ R$600 Million Debentures Offering

iTaxi.pl’s Financing Round

Auctus Capital’s Acquisition Of Minority Stake In Johannes Martens Spedition

Smart Reporting’s €23 Million Series C Financing Round

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

SC Ventures’ $100 Million Joint Venture With SBI Holdings

GreenCorp’s Acquisition of Emad Bakeries

Guesty’s Financing Round

ReNew Energy Global’s Transaction Agreement with JERA

AG&P LNG Marketing’s Investment Round

Shenyang Automobile’s $2.3 Billion Acquisition Of Huachen

Securities Regulation Partner Emily Gordy Joins King & Spalding in Washington, D.C.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Securities Regulation Partner Emily Gordy Joins King & Spalding in Washington, D.C.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Paul Hastings Adds Premier Private Equity Buyout Team

Inmune Bio’s $40.0 Million Shares Offering

Author: Martina Bellini